Lataa...
Phlebitis as a consequence of peripheral intravenous administration of cisatracurium besylate in critically ill patients
This case report series describes 3 cases of cisatracurium besylate associated phlebitis after an infusion period of 14–20 hours. No similar cases have been reported in the literature. Association of phlebitis with another neuromuscular blocking agent, atracurium, has been described in the literatur...
Tallennettuna:
| Julkaisussa: | BMJ Case Rep |
|---|---|
| Päätekijät: | , , , |
| Aineistotyyppi: | Artigo |
| Kieli: | Inglês |
| Julkaistu: |
BMJ Publishing Group
2016
|
| Aiheet: | |
| Linkit: | https://ncbi.nlm.nih.gov/pmc/articles/PMC5073701/ https://ncbi.nlm.nih.gov/pubmed/27698008 https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1136/bcr-2016-216448 |
| Tagit: |
Lisää tagi
Ei tageja, Lisää ensimmäinen tagi!
|